QSAM Biosciences EBITDA
Что обозначает EBITDA в QSAM Biosciences?
EBITDA QSAM Biosciences, Inc. является -$1.30
Какое определение для EBITDA?
EBITDA - это прибыль компании до вычета процентов, налогов, обесценивания и амортизации, а также является бухгалтерской мерой, рассчитанной с использованием чистой прибыли компании до вычета процентных расходов, налогов, обесценивания и амортизации в качестве показателя текущей операционной прибыли компании.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA компаний в Health Care сектор на OTC по сравнению с QSAM Biosciences
Что делает QSAM Biosciences?
QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.
Компании с ebitda похож на QSAM Biosciences
- Save Foods имеет EBITDA из -$1.30
- Transatlantic Mining имеет EBITDA из -CAD$1.30
- Ascent Resources plc имеет EBITDA из -£1.30
- Tie Kinetix имеет EBITDA из -€1.30
- TIE Kinetix N.V имеет EBITDA из -€1.30
- Resonate Blends имеет EBITDA из -$1.30
- QSAM Biosciences имеет EBITDA из -$1.30
- Renascor Resources имеет EBITDA из -AUD$1.30
- Kilitch Drugs (India) имеет EBITDA из -₨1.30
- Providence Resources Plc имеет EBITDA из -€1.30
- Providence Resources P.l.c имеет EBITDA из -€1.30
- TriStar Gold имеет EBITDA из -$1.30
- Radius Gold имеет EBITDA из -CAD$1.30